NR1I2 and breast carcinoma: Kaplan–Meier survival curves indicated that breast carcinoma patients presenting high PXR expression presented significantly shorter OS (Overall Survival) times compared to those with low PXR expression (Figure 2A, log-rank test, p = 0.0009).